Exodus Point Capital Management, LP Gilead Sciences, Inc. Transaction History

Exodus Point Capital Management, LP

$10.1 Billion
Q1 2025

A detailed history of Exodus Point Capital Management, LP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 104,663 shares of GILD stock, worth $11.6 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

104,663

Holding current value

$11.6 Million

% of portfolio

0.12%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$89.14 - $117.41 $9.33 Million - $12.3 Million	104,663 New	104,663 $11.7 Million
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $6.68 Million - $8.42 Million	100,282 Added 209.99%	148,038 $12.4 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $3.02 Million - $3.48 Million	47,756 New	47,756 $3.28 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $21.2 Million - $24.2 Million	279,278 New	279,278 $21.5 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $8.06 Million - $11.6 Million	129,276 New	129,276 $11.1 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $336,698 - $384,596	-5,655 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$57.72 - $65.01 $1.45 Million - $1.63 Million	-25,128 Reduced 81.63%	5,655 $350,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $1.78 Million - $2.23 Million	30,783 New	30,783 $1.83 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $3.22 Million - $3.68 Million	-53,683 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.41 Million - $2.75 Million	42,591 Added 383.98%	53,683 $3.13 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $1.01 Million - $1.26 Million	-16,198 Reduced 59.36%	11,092 $701,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.63 Million - $1.9 Million	-22,574 Reduced 45.27%	27,290 $2.1 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.12 Million - $4 Million	49,864 New	49,864 $3.73 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $1.84 Million - $2.02 Million	-29,839 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.71 Million - $2.99 Million	-43,343 Reduced 59.23%	29,839 $1.89 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $1.15 Million - $1.29 Million	-18,634 Reduced 20.29%	73,182 $4.94 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $4.87 Million - $5.45 Million	77,852 Added 557.52%	91,816 $5.97 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $845,380 - $1.1 Million	13,964 New	13,964 $873,000

Others Institutions Holding GILD

# of Institutions

2,289

Shares Held

997M

Call Options Held

9.62M

Put Options Held

10M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $139B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Gilead Sciences, Inc. Transaction History